Serving hundreds of leading biopharmaceutical companies globally:

Generated: February 17, 2019

DrugPatentWatch Database Preview

Alpharma Us Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for ALPHARMA US PHARMS, and what generic and branded alternatives to ALPHARMA US PHARMS drugs are available?

ALPHARMA US PHARMS has sixty-one approved drugs.

Summary for Alpharma Us Pharms

US Patents:	0
Tradenames:	43
Ingredients:	40
NDAs:	61

Drugs and US Patents for Alpharma Us Pharms

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alpharma Us Pharms	ERYTHROMYCIN	erythromycin	SOLUTION;TOPICAL	062328-001	Apr 19, 1982		DISCN	No	No		➤ Sign Up				➤ Sign Up
Alpharma Us Pharms	MYKINAC	nystatin	OINTMENT;TOPICAL	062731-001	Sep 22, 1986		DISCN	No	No		➤ Sign Up				➤ Sign Up
Alpharma Us Pharms	DIPHENHYDRAMINE HYDROCHLORIDE	diphenhydramine hydrochloride	SYRUP;ORAL	070497-001	Apr 25, 1989		DISCN	No	No		➤ Sign Up				➤ Sign Up
Alpharma Us Pharms	THIORIDAZINE HYDROCHLORIDE	thioridazine hydrochloride	CONCENTRATE;ORAL	087766-001	Apr 26, 1983		DISCN	No	No		➤ Sign Up				➤ Sign Up
Alpharma Us Pharms	PROCHLORPERAZINE EDISYLATE	prochlorperazine edisylate	SYRUP;ORAL	087154-001	Sep 1, 1982		DISCN	No	No		➤ Sign Up				➤ Sign Up
Alpharma Us Pharms	ERYTHROMYCIN ETHYLSUCCINATE	erythromycin ethylsuccinate	SUSPENSION;ORAL	062200-001	Approved Prior to Jan 1, 1982		DISCN	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Expired US Patents for Alpharma Us Pharms

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-002	Approved Prior to Jan 1, 1982	4,620,974	➤ Sign Up
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-004	Approved Prior to Jan 1, 1982	4,620,974	➤ Sign Up
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-006	Approved Prior to Jan 1, 1982	4,620,974	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health

Colorcon

Medtronic

Deloitte

Chubb

AstraZeneca

Johnson and Johnson

Farmers Insurance

Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.